Cilia Plays a Pivotal Role in the Hypersecretion of Airway Mucus in Mice

Current Molecular Pharmacology · Published 2025-04-11 · DOI 10.2174/0118761429368288250401054301

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0118761429368288250401054301

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs · Current Molecular Pharmacology · 2026 · Same journal
Chrysin: A Potential Antiandrogen Ligand to Mutated Androgen Receptors in Prostate Cancer · Current Molecular Pharmacology · 2025 · Same journal
Protective Effect of Platycodin D on Allergic Rhinitis in Mice through DPP4/JAK2/STAT3 Pathway Inhibition · Current Molecular Pharmacology · 2025 · Same journal
Neuroprotective Potential of Tanshinone-IIA in Mitigating Propionic Acidinduced Experimental Autism-like Behavioral and Neurochemical Alterations: Insights into c-JNK and p38MAPK Pathways · Current Molecular Pharmacology · 2024 · Same journal
Regulatory Mechanisms of STAT3 in GBM and its Impact on TMZ Resistance · Current Molecular Pharmacology · 2025 · Same journal
Optimization of bioinformatics-designed thiazolide derivatives as SARS-CoV-2 nucleocapsid protein inhibitors · Current Molecular Pharmacology · 2026 · Same journal
Doxazosin Attenuates Development of Testosterone Propionate-induced Prostate Growth by regulating TGF-β/Smad Signaling Pathway, Prostate-specific Antigen Expression and Reversing Epithelial-Mesenchymal Transition in Mice and Stroma Cells · Current Molecular Pharmacology · 2025 · Same journal
Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma · Current Molecular Pharmacology · 2025 · Same journal
IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease · Current Molecular Pharmacology · 2026 · Same journal
Galectin-1 Suppresses FBP1 to Activate RAS/ERK Signaling and Facilitate Intrahepatic Cholangiocarcinoma Progression · Current Molecular Pharmacology · 2026 · Same journal